应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02171 科济药业-B
交易中 05-09 10:51:05
15.300
-0.180
-1.16%
最高
15.960
最低
15.020
成交量
59.95万
今开
15.020
昨收
15.480
日振幅
6.07%
总市值
87.67亿
流通市值
87.67亿
总股本
5.73亿
成交额
926.63万
换手率
0.10%
流通股本
5.73亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每日卖空追踪 | 科济药业-B 05月08日卖空量成交25.4万股,卖空比例为12.77%
市场透视 · 05-08 08:30
每日卖空追踪 | 科济药业-B 05月08日卖空量成交25.4万股,卖空比例为12.77%
科济药业-B05月08日遭主力抛售498.1万元
市场透视 · 05-08 08:15
科济药业-B05月08日遭主力抛售498.1万元
科济药业-B盘中异动 急速跳水5.06%
市场透视 · 05-08 03:42
科济药业-B盘中异动 急速跳水5.06%
每日卖空追踪 | 科济药业-B 05月06日卖空量成交32.1万股,卖空比例为8.83%
市场透视 · 05-06 11:18
每日卖空追踪 | 科济药业-B 05月06日卖空量成交32.1万股,卖空比例为8.83%
港股异动 | 科济药业-B(02171)再涨超7% 治疗骨髓瘤药物临床研究结果将于欧洲EHA年会发布
智通财经 · 05-06 03:51
港股异动 | 科济药业-B(02171)再涨超7% 治疗骨髓瘤药物临床研究结果将于欧洲EHA年会发布
科济药业-B盘中异动 早盘大幅拉升5.02%报16.740港元
市场透视 · 05-06
科济药业-B盘中异动 早盘大幅拉升5.02%报16.740港元
每日卖空追踪 | 科济药业-B 05月02日卖空量成交6.55万股,卖空比例为6.55%
市场透视 · 05-02
每日卖空追踪 | 科济药业-B 05月02日卖空量成交6.55万股,卖空比例为6.55%
每日卖空追踪 | 科济药业-B 04月30日卖空量成交9万股,卖空比例为7.78%
市场透视 · 04-30
每日卖空追踪 | 科济药业-B 04月30日卖空量成交9万股,卖空比例为7.78%
港股异动 | 科济药业-B(02171)午后涨超6% CT071的摘要已获EHA年会接受以壁报展示呈列
智通财经 · 04-29
港股异动 | 科济药业-B(02171)午后涨超6% CT071的摘要已获EHA年会接受以壁报展示呈列
科济药业-B盘中异动 股价大涨5.11%报16.040港元
市场透视 · 04-29
科济药业-B盘中异动 股价大涨5.11%报16.040港元
对话科济药业李宗海:与抗癌药研发赛跑近30年,一场有关癌症治愈的挑战和探索
时代财经 · 04-29
对话科济药业李宗海:与抗癌药研发赛跑近30年,一场有关癌症治愈的挑战和探索
科济药业-B(02171):CT071的摘要已获2025年EHA年会接受以壁报展示呈列
智通财经 · 04-29
科济药业-B(02171):CT071的摘要已获2025年EHA年会接受以壁报展示呈列
科济药业-B:CT071的摘要已获2025年EHA年会接受以壁报展示呈列
格隆汇资讯 · 04-29
科济药业-B:CT071的摘要已获2025年EHA年会接受以壁报展示呈列
每日卖空追踪 | 科济药业-B 04月28日卖空量成交11.9万股,卖空比例为6.3%
市场透视 · 04-28
每日卖空追踪 | 科济药业-B 04月28日卖空量成交11.9万股,卖空比例为6.3%
每日卖空追踪 | 科济药业-B 04月22日卖空量成交87.65万股,卖空比例为16.84%
市场透视 · 04-22
每日卖空追踪 | 科济药业-B 04月22日卖空量成交87.65万股,卖空比例为16.84%
科济药业-B04月22日获主力加仓109万元
市场透视 · 04-22
科济药业-B04月22日获主力加仓109万元
科济药业-B盘中异动 早盘股价大涨5.02%报13.380港元
市场透视 · 04-22
科济药业-B盘中异动 早盘股价大涨5.02%报13.380港元
每日卖空追踪 | 科济药业-B 04月17日卖空量成交25.35万股,卖空比例为16.72%
市场透视 · 04-17
每日卖空追踪 | 科济药业-B 04月17日卖空量成交25.35万股,卖空比例为16.72%
科济药业-B盘中异动 早盘股价大涨5.35%报13.000港元
市场透视 · 04-17
科济药业-B盘中异动 早盘股价大涨5.35%报13.000港元
科济药业-B(02171)授出353.55万份购股权及169.8万份受限制股份单位
智通财经 · 04-16
科济药业-B(02171)授出353.55万份购股权及169.8万份受限制股份单位
加载更多
公司概况
公司名称:
科济药业-B
所属市场:
SEHK
上市日期:
--
主营业务:
科济药业控股有限公司是一家主要从事创新嵌合抗原受体(CAR)T 细胞疗法发现、开发及销售业务的中国投资控股公司。该公司的疗法用于治疗血液恶性肿瘤和实体瘤。该公司已开发升级版靶向B细胞成熟抗原(BCMA)的CAR-T产品CT053。CT053为其的唯一核心候选产品。该公司在中国和美国开展业务。
发行价格:
--
{"stockData":{"symbol":"02171","market":"HK","secType":"STK","nameCN":"科济药业-B","latestPrice":15.3,"timestamp":1746758963957,"preClose":15.48,"halted":0,"volume":599500,"delay":0,"floatShares":573000000,"shares":573000000,"eps":-1.5480791037002486,"marketStatus":"交易中","change":-0.18,"latestTime":"05-09 10:51:05","open":15.02,"high":15.96,"low":15.02,"amount":9266260,"amplitude":0.060724,"askPrice":15.36,"askSize":5000,"bidPrice":15.3,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":-1.5480791037002486,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1746763200000},"marketStatusCode":2,"adr":0,"listingDate":1623945600000,"exchange":"SEHK","adjPreClose":15.48,"openAndCloseTimeList":[[1746754200000,1746763200000],[1746766800000,1746777600000]],"volumeRatio":1.161143,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02171","defaultTab":"news","newsList":[{"id":"2533537903","title":"每日卖空追踪 | 科济药业-B 05月08日卖空量成交25.4万股,卖空比例为12.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533537903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533537903?lang=zh_cn&edition=full","pubTime":"2025-05-08 16:30","pubTimestamp":1746693026,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间05月08日,跌4.44%,卖空量成交25.4万股%,较上一交易日减少35.7%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508175201a6d7786c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508175201a6d7786c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","BK1574","BK1585","02171"],"gpt_icon":0},{"id":"2533977116","title":"科济药业-B05月08日遭主力抛售498.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533977116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533977116?lang=zh_cn&edition=full","pubTime":"2025-05-08 16:15","pubTimestamp":1746692108,"startTime":"0","endTime":"0","summary":"05月08日, 科济药业-B股价跌4.44%,报收15.48元,成交金额3072.7万元,换手率0.35%,振幅5.43%,量比0.97。科济药业-B今日主力资金净流出498.1万元,上一交易日主力净流出680.9万元。该股近5个交易日下跌3.13%,主力资金累计净流出1144.6万元;近20日主力资金累计净流出2282.0万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508172912a4767a7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508172912a4767a7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02171","BK1585","BK1574","BK1587","BK1161"],"gpt_icon":0},{"id":"2533945651","title":"科济药业-B盘中异动 急速跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533945651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533945651?lang=zh_cn&edition=full","pubTime":"2025-05-08 11:42","pubTimestamp":1746675722,"startTime":"0","endTime":"0","summary":"2025年05月08日临近午盘11时42分,科济药业-B股票出现波动,股价急速跳水5.06%。资金方面,该股资金流入560.706万港元,流出1144万港元。机构评级方面,在所有1家参与评级的机构中,100%的券商给予卖出建议,无券商给予买入、持有建议。科济药业-B股票所在的生物技术行业中,整体涨幅为0.11%。科济药业-B公司简介:科济药业控股有限公司是一家主要从事探索、研发细胞疗法的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050811420294effdf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050811420294effdf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1585","BK1587","BK1574","02171"],"gpt_icon":0},{"id":"2533681070","title":"每日卖空追踪 | 科济药业-B 05月06日卖空量成交32.1万股,卖空比例为8.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533681070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533681070?lang=zh_cn&edition=full","pubTime":"2025-05-06 19:18","pubTimestamp":1746530329,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间05月06日,涨5.4%,卖空量成交32.1万股%,较上一交易日增加170.89%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506192505a6d4f887&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506192505a6d4f887&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","BK1587","BK1161","02171","BK1574"],"gpt_icon":0},{"id":"2533104965","title":"港股异动 | 科济药业-B(02171)再涨超7% 治疗骨髓瘤药物临床研究结果将于欧洲EHA年会发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2533104965","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533104965?lang=zh_cn&edition=full","pubTime":"2025-05-06 11:51","pubTimestamp":1746503488,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,科济药业-B再涨超7%,截至发稿,涨6.65%,报17港元,成交额3685.29万港元。消息面上,消息面上,科济药业公布,旗下CT071用于治疗新诊断的多发性骨髓瘤研究者发起的临床试验研究结果摘要,已被2025年欧洲血液学协会年会接受,将在壁报展示环节进行发布。根据协议条款,优恺泽获得科济药业治疗多发性骨髓瘤、浆细胞白血病的通用型BCMA CAR-T细胞产品以及治疗B细胞肿瘤的通用型CD19/CD20 CAR-T细胞产品在中国内地的研发、生产与商业化的独家权利。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289452.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1585","BK1161","02171","BK1587"],"gpt_icon":0},{"id":"2533515359","title":"科济药业-B盘中异动 早盘大幅拉升5.02%报16.740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533515359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533515359?lang=zh_cn&edition=full","pubTime":"2025-05-06 09:43","pubTimestamp":1746495796,"startTime":"0","endTime":"0","summary":"2025年05月06日早盘09时43分,科济药业-B股票出现波动,股价大幅拉升5.02%。截至发稿,该股报16.740港元/股,成交量57.1万股,换手率0.10%,振幅5.14%。资金方面,该股资金流入350.605万港元,流出544.686万港元。科济药业-B股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,科济药业-B、康宁杰瑞制药-B、荃信生物-B涨幅较大,振幅较大的相关个股有百奥赛图-B、同源康医药-B、诺诚健华,振幅分别为8.78%、6.84%、6.51%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050609431694ed5f8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050609431694ed5f8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02171","BK1585","BK1587","BK1161","BK1574"],"gpt_icon":0},{"id":"2532892024","title":"每日卖空追踪 | 科济药业-B 05月02日卖空量成交6.55万股,卖空比例为6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532892024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532892024?lang=zh_cn&edition=full","pubTime":"2025-05-02 16:30","pubTimestamp":1746174628,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间05月02日,涨2.57%,卖空量成交6.55万股,较上一交易日减少27.22%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502163610a46fcaea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502163610a46fcaea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","BK1574","BK1161","BK1587","02171"],"gpt_icon":0},{"id":"2531084212","title":"每日卖空追踪 | 科济药业-B 04月30日卖空量成交9万股,卖空比例为7.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531084212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531084212?lang=zh_cn&edition=full","pubTime":"2025-04-30 17:49","pubTimestamp":1746006564,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间04月30日,跌2.75%,卖空量成交9万股,较上一交易日减少14.29%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430175533a46d82af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430175533a46d82af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","02171","BK1585","BK1574"],"gpt_icon":0},{"id":"2531259522","title":"港股异动 | 科济药业-B(02171)午后涨超6% CT071的摘要已获EHA年会接受以壁报展示呈列","url":"https://stock-news.laohu8.com/highlight/detail?id=2531259522","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531259522?lang=zh_cn&edition=full","pubTime":"2025-04-29 14:05","pubTimestamp":1745906704,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,科济药业-B(02171)午后涨超6%,截至发稿,涨5.24%,报16.06港元,成交额1939.9万港元。消息面上,科济药业公布,旗下CT071用于治疗新诊断的多发性骨髓瘤(NDMM)研究者发起的临床试验研究结果摘要,已被2025年欧洲血液学协会(EHA)年会接受,将在壁报展示环节进行发布。据介绍,CT071用于治疗复发/难治多发性骨髓瘤或复发/难治浆细胞白血病(PCL)。一项研究者发起的临床试验正在中国开展,旨在初步评估CT071治疗复发/难治多发性骨髓瘤或浆细胞白血病的安全性和有效性。另一项研究者发起的试验正在中国开展,用于治疗新诊断的多发性骨髓瘤(NDMM)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287172.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","BK1585","BK1587","02171"],"gpt_icon":0},{"id":"2531228049","title":"科济药业-B盘中异动 股价大涨5.11%报16.040港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531228049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531228049?lang=zh_cn&edition=full","pubTime":"2025-04-29 13:47","pubTimestamp":1745905664,"startTime":"0","endTime":"0","summary":"2025年04月29日下午盘13时47分,科济药业-B股票出现波动,股价急速拉升5.11%。截至发稿,该股报16.040港元/股,成交量112.8万股,换手率0.20%,振幅5.90%。资金方面,该股资金流入1191.65万港元,流出467.162万港元。机构评级方面,在所有1家参与评级的机构中,100%的券商给予卖出建议,无券商给予买入、持有建议。科济药业-B股票所在的生物技术行业中,整体涨幅为2.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429134744a46b8a52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429134744a46b8a52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","02171","BK1587","BK1574","BK1161"],"gpt_icon":0},{"id":"2531321718","title":"对话科济药业李宗海:与抗癌药研发赛跑近30年,一场有关癌症治愈的挑战和探索","url":"https://stock-news.laohu8.com/highlight/detail?id=2531321718","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531321718?lang=zh_cn&edition=full","pubTime":"2025-04-29 10:32","pubTimestamp":1745893933,"startTime":"0","endTime":"0","summary":"“希望有朝一日能治愈癌症患者。”在接受时代财经专访时,李宗海坦言,这个愿望从二十多年前萌生开始,到现在也没变过。李宗海是科济药业(02171.HK)创始人、首席执行官。在进行这次采访时,李宗海正在赶往医院探望生病好友的路上。这个画面恰似他职业生涯的隐喻——始终在与时间赛跑,追赶癌症夺走生命的脚步。愿望的萌芽,来源于李宗海在1996年冬天的经历。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504293392526730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1585","02171","BK1587","BK1161"],"gpt_icon":0},{"id":"2531297990","title":"科济药业-B(02171):CT071的摘要已获2025年EHA年会接受以壁报展示呈列","url":"https://stock-news.laohu8.com/highlight/detail?id=2531297990","media":"智通财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531297990?lang=zh_cn&edition=full","pubTime":"2025-04-29 08:42","pubTimestamp":1745887354,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科济药业-B 发布公告,,CT071用于治疗新诊断的多发性骨髓瘤的研究者发起的临床试验 的研究结果摘要已被2025年欧洲血液学协会“年会接受,将在壁报展示环节进行发布。摘要和进一步信息将于欧洲中部时间2025年5月14 日15:30后公布。一项研究者发起的临床试验正在中国开展,旨在初步评估CT071治疗复发╱难治多发性骨髓瘤或浆细胞白血病的安全性和有效性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"科济药业-B(02171):CT071的摘要已获2025年EHA年会接受以壁报展示呈列","news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02171","BK1585","BK1587","BK1161","BK1574"],"gpt_icon":0},{"id":"2531329283","title":"科济药业-B:CT071的摘要已获2025年EHA年会接受以壁报展示呈列","url":"https://stock-news.laohu8.com/highlight/detail?id=2531329283","media":"格隆汇资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531329283?lang=zh_cn&edition=full","pubTime":"2025-04-29 08:28","pubTimestamp":1745886525,"startTime":"0","endTime":"0","summary":"格隆汇4月29日丨科济药业-B(02171.HK)发布公告,CT071(一种靶向GPRC5D的自体CAR-T细胞产品)用于治疗新诊断的多发性骨髓瘤(NDMM)的研究者发起的临床试验 (NCT06407947)的研究结果摘要已被2025年欧洲血液学协会(“EHA”)年会接受,将在壁报展示环节进行发布。摘要和进一步信息将于欧洲中部时间2025年5月14日15:30后公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042908284994e696f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042908284994e696f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1585","02171","BK1574","BK1161"],"gpt_icon":0},{"id":"2530285567","title":"每日卖空追踪 | 科济药业-B 04月28日卖空量成交11.9万股,卖空比例为6.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530285567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530285567?lang=zh_cn&edition=full","pubTime":"2025-04-28 19:59","pubTimestamp":1745841551,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间04月28日,跌0.91%,卖空量成交11.9万股,较上一交易日减少50.83%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428211318a6cbba72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428211318a6cbba72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02171","BK1585","BK1587"],"gpt_icon":0},{"id":"2529309787","title":"每日卖空追踪 | 科济药业-B 04月22日卖空量成交87.65万股,卖空比例为16.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529309787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529309787?lang=zh_cn&edition=full","pubTime":"2025-04-22 19:54","pubTimestamp":1745322844,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间04月22日,涨16.17%,卖空量成交87.65万股,较上一交易日增加245.76%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422195412a4626cce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422195412a4626cce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","BK1574","02171","BK1585"],"gpt_icon":0},{"id":"2529212353","title":"科济药业-B04月22日获主力加仓109万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529212353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529212353?lang=zh_cn&edition=full","pubTime":"2025-04-22 16:16","pubTimestamp":1745309798,"startTime":"0","endTime":"0","summary":"04月22日, 科济药业-B股价涨16.17%,报收14.80元,成交金额7573万元,换手率0.91%,振幅21.19%,量比2.59。科济药业-B今日主力资金净流入109万元,上一交易日主力净流入7万元。该股近5个交易日上涨21.51%,主力资金累计净流出134万元;近20日主力资金累计净流出783万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171326a6c38c25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171326a6c38c25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","BK1574","BK1585","02171"],"gpt_icon":0},{"id":"2529362417","title":"科济药业-B盘中异动 早盘股价大涨5.02%报13.380港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529362417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529362417?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:43","pubTimestamp":1745286225,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘09时43分,科济药业-B股票出现异动,股价快速上涨5.02%。截至发稿,该股报13.380港元/股,成交量17.1万股,换手率0.03%,振幅5.18%。资金方面,该股资金流入152.267万港元,流出35.747万港元。科济药业-B股票所在的生物技术行业中,整体涨幅为0.69%。其相关个股中,歌礼制药-B、诺诚健华、荃信生物-B涨幅较大,振幅较大的相关个股有博安生物、荃信生物-B、科伦博泰生物-B,振幅分别为13.23%、11.22%、10.72%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042209434594dd73d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042209434594dd73d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1585","BK1161","02171","BK1574"],"gpt_icon":0},{"id":"2528328719","title":"每日卖空追踪 | 科济药业-B 04月17日卖空量成交25.35万股,卖空比例为16.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528328719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528328719?lang=zh_cn&edition=full","pubTime":"2025-04-17 19:52","pubTimestamp":1744890764,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间04月17日,涨3.24%,卖空量成交25.35万股,较上一交易日减少25.22%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417195247a45c7a9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417195247a45c7a9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","BK1574","02171","BK1585"],"gpt_icon":0},{"id":"2528782163","title":"科济药业-B盘中异动 早盘股价大涨5.35%报13.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528782163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528782163?lang=zh_cn&edition=full","pubTime":"2025-04-17 09:47","pubTimestamp":1744854470,"startTime":"0","endTime":"0","summary":"2025年04月17日早盘09时47分,科济药业-B股票出现异动,股价急速上涨5.35%。截至发稿,该股报13.000港元/股,成交量20.4万股,换手率0.04%,振幅5.51%。资金方面,该股资金流入149.45万港元,流出100.117万港元。科济药业-B股票所在的生物技术行业中,整体跌幅为1.45%。其相关个股中,博安生物、诺诚健华、科济药业-B涨幅较大,振幅较大的相关个股有博安生物、康诺亚-B、诺诚健华,振幅分别为8.50%、7.56%、7.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417094750aa2c7258&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417094750aa2c7258&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","02171","BK1574","BK1587","BK1161"],"gpt_icon":0},{"id":"2527244378","title":"科济药业-B(02171)授出353.55万份购股权及169.8万份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2527244378","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527244378?lang=zh_cn&edition=full","pubTime":"2025-04-16 22:22","pubTimestamp":1744813348,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科济药业-B(02171)发布公告,于2025年4月16日,公司根据首次公开发售后购股权计划的条款向167名购股权承授人授出353.55万份购股权,但须待购股权承授人接纳后方可作实。于2025年4月16日,公司根据首次公开发售后受限制股份单位计划的条款向165名受限制股份单位承授人授出169.8万份受限制股份单位,但须待受限制股份单位承授人接纳后方可作实。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1279787.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1161","BK1574","02171","BK1585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carsgen.com","stockEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":0.3871},{"period":"3month","weight":0.6574},{"period":"6month","weight":1.0476},{"period":"1year","weight":1.5886},{"period":"ytd","weight":0.6808}],"compareEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":0.1316},{"period":"3month","weight":0.0777},{"period":"6month","weight":0.0988},{"period":"1year","weight":0.2436},{"period":"ytd","weight":0.1354}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"科济药业控股有限公司是一家主要从事创新嵌合抗原受体(CAR)T 细胞疗法发现、开发及销售业务的中国投资控股公司。该公司的疗法用于治疗血液恶性肿瘤和实体瘤。该公司已开发升级版靶向B细胞成熟抗原(BCMA)的CAR-T产品CT053。CT053为其的唯一核心候选产品。该公司在中国和美国开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.109168},{"month":2,"riseRate":0.75,"avgChangeRate":0.310052},{"month":3,"riseRate":0,"avgChangeRate":-0.128154},{"month":4,"riseRate":0.25,"avgChangeRate":-0.092431},{"month":5,"riseRate":0.5,"avgChangeRate":0.006859},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.000476},{"month":7,"riseRate":0.5,"avgChangeRate":-0.003478},{"month":8,"riseRate":0.5,"avgChangeRate":0.066002},{"month":9,"riseRate":0.5,"avgChangeRate":0.083194},{"month":10,"riseRate":0.75,"avgChangeRate":0.067361},{"month":11,"riseRate":0.5,"avgChangeRate":0.049974},{"month":12,"riseRate":0.5,"avgChangeRate":-0.036587}],"exchange":"SEHK","name":"科济药业-B","nameEN":"CARSGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科济药业-B(02171)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科济药业-B(02171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科济药业-B,02171,科济药业-B股票,科济药业-B股票老虎,科济药业-B股票老虎国际,科济药业-B行情,科济药业-B股票行情,科济药业-B股价,科济药业-B股市,科济药业-B股票价格,科济药业-B股票交易,科济药业-B股票购买,科济药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科济药业-B(02171)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科济药业-B(02171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}